Mark Nordlicht insider trades: Navidea Biopharmaceuticals (NAVB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Mark reports to the SEC
Open-market buys and sales
14 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 2, 2014 | NAVB | ↓ Sell | 60,000 | $1.36 | $82K | By Platinum Partners Value Arbitrage Fun | Sep 4, 2014 (2d) |
| Jun 30, 2014 | ECTE | ↑ Buy | 65,739 | $2.20 | $145K | By Platinum Partners Liquid Opportunity | Jul 1, 2014 (1d) |
| Jun 26, 2014 | ECTE | ↑ Buy | 17,300 | $2.20 | $38K | By Platinum Partners Liquid Opportunity | Jun 27, 2014 (1d) |
| Jun 24, 2014 | ECTE | ↑ Buy | 16,961 | $2.20 | $37K | By Platinum Partners Liquid Opportunity | Jun 24, 2014 (0d) |
| Dec 10, 2013 | ECTE | ↑ Buy | 55,655 | $2.75 | $153K | By Platinum Partners Value Arbitrage Fun | Dec 12, 2013 (2d) |
| Dec 10, 2013 | ECTE | ↑ Buy | 13,914 | $2.75 | $38K | By Platinum Partners Liquid Opportunity | Dec 12, 2013 (2d) |
| Sep 25, 2009 | DLYT.OB | ↓ Sell | 86,536 | $1.54 | $133K | Direct | Nov 4, 2009 (40d) |
| Aug 7, 2009 | NNAN.OB | ↓ Sell | 426,244 | $0.02 | $9K | Direct | Aug 12, 2009 (5d) |
| Apr 29, 2009 | NNAN.OB | ↓ Sell | 69,311 | $0.15 | $10K | Direct | May 8, 2009 (9d) |
| Feb 26, 2009 | OPBL.OB | ↓ Sell | 4,095,075 | $0.02 | $74K | Direct | Feb 27, 2009 (1d) |
| Apr 10, 2007 | OPBL.OB | ↓ Sell | 7,000,000 | $2.69 | $18.8M | Direct | Apr 11, 2007 (1d) |
| Jul 10, 2006 | PGRI | ↑ Buy | 1,000 | $7.22 | $7K | Direct | Jul 12, 2006 (2d) |
| Jul 5, 2006 | PGRI | ↑ Buy | 10,000 | $7.20 | $72K | Direct | Jul 5, 2006 (0d) |
| Jun 26, 2006 | PGRI | ↑ Buy | 10,000 | $7.19 | $72K | Direct | Jun 27, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Mark Nordlicht's insider trades
Mark Nordlicht is a 10% owner of Navidea Biopharmaceuticals (NAVB). Since Jun 26, 2006, Mark has reported 8 open-market purchases worth $562K and 6 sales worth $19.1M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include other transactions (5 filings), conversions (2 filings), option exercises (1 filing), gifts (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NAVB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.